185 Participants Needed

Education Program for Kidney Disease

(iPREP-RRT Trial)

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Chicago

What You Need to Know Before You Apply

What is the purpose of this trial?

Intensive Patient Referral and Education Program prior to Renal Replacement Therapy (iPREP-RRT) is a 12-week intervention that identifies hospitalized African Americans with advanced chronic kidney disease (CKD) and provides them with hospital- and community-based education, navigation and self-management support. Participants will be randomized to the iPREP-RRT intervention versus enhanced usual care.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

Is the Education Program for Kidney Disease safe for humans?

The available research does not provide specific safety data for the Education Program for Kidney Disease or its related programs like iPREP-RRT. However, the studies highlight the importance of patient safety in chronic kidney disease management, emphasizing the need for careful monitoring and communication to prevent adverse safety events.12345

How is the iPREP-RRT treatment different from other treatments for kidney disease?

The iPREP-RRT treatment is unique because it focuses on an intensive education and referral program, helping patients understand and choose the most suitable renal replacement therapy (RRT) for their condition, which can lead to better preparation and improved outcomes compared to standard treatments that may not emphasize patient education and involvement.678910

What data supports the effectiveness of the treatment Intensive Patient Referral and Education Program, iPREP-RRT?

Research shows that early patient referral to kidney specialists and education programs can lead to better preparation for kidney treatment and improved survival rates. Additionally, virtual education sessions have been effective in increasing patient access to necessary information, which can help them make informed decisions about their treatment options.3691112

Are You a Good Fit for This Trial?

This trial is for hospitalized African Americans with advanced chronic kidney disease (CKD). Participants should not have started renal replacement therapy. The program aims to educate and support them in managing their health, focusing on blood pressure control and CKD self-management.

Inclusion Criteria

Self-identify as Black or African American
Admitted to the University of Chicago inpatient general medicine service
My kidney function is significantly reduced (Stage 3B or worse).
See 1 more

Exclusion Criteria

I am unable to give consent because of my mental condition.
Non-English speaking
I am currently in the Intensive Care Unit.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Hospital-based Intervention

Participants receive education and self-management support during hospitalization

1 day
1 in-person session

Community-based Intervention

Participants receive ongoing education and support through in-person sessions, phone calls, and text messages

12 weeks
1 in-person session, phone sessions at weeks 4 and 8, weekly text messages

Follow-up

Participants are monitored for knowledge, self-efficacy, and health intent after the intervention

4 weeks
Assessments at weeks 4, 8, 12, and 16

What Are the Treatments Tested in This Trial?

Interventions

  • Intensive Patient Referral and Education Program
Trial Overview The iPREP RRT study tests a 12-week program combining hospital- and community-based education, navigation, and self-management support against enhanced usual care. It includes commitment exercises, educational sessions, text messages for health management reinforcement, and blood pressure monitoring.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intensive Intervention (iPREP RRT)Experimental Treatment5 Interventions
The intervention is administered by a patient educator (PE), a culturally concordant health educator. S/he will review the CKD and RRT education materials on a tablet device with the participant, answer any questions they have, and using motivational interviewing techniques get a commitment for future action. The participant and the patient educator will work together to decide on potential CKD self-management and RRT options and/or next steps. The PE will teach the participant how to use the home blood pressure monitor and will leave it with the participant. The patient educator will check in with the participant through text messages and follow-up phone calls.
Group II: Enhanced Usual CarePlacebo Group2 Interventions
The enhanced usual care is administered by a patient educator (PE), a culturally concordant health educator. The PE will drop off written general health education materials. The patient educator will check in with the participant through text messages.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Chicago

Lead Sponsor

Trials
1,086
Recruited
844,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+

Published Research Related to This Trial

There is a significant gap between the current management of advanced chronic kidney disease and the ideal care needed to reduce cardiovascular risks and improve patient outcomes, highlighting the need for better infrastructures and training.
Implementing multidisciplinary advanced kidney disease clinics can enhance patient survival and quality of life, while addressing issues like late nephrologist referrals and inadequate patient education on renal replacement therapy options.
'Reality and desire' in the care of advanced chronic kidney disease.Marrón, B., Craver, L., Remón, C., et al.[2020]
A cooperation program involving nephrologists and dialysis specialists significantly improved patient education and management for chronic kidney disease (CKD), with 92.1% of patients having their prescriptions adjusted and 96.8% receiving nutrition education.
Participation in an educational program for peritoneal dialysis (PD) led to an increase in PD selectivity from 8.8% to 15.0% over two years, highlighting the importance of specialist intervention in enhancing treatment options and patient quality of life.
Implementation of a cooperative program for peritoneal dialysis.Okada, K., Abe, M., Soma, M.[2019]
Many patients with end-stage renal disease are not properly prepared for starting renal replacement therapy (RRT), which can impact their treatment outcomes.
Early referral to nephrologists and community kidney disease screening can significantly enhance patient preparation for RRT and is linked to improved survival rates after treatment initiation.
Better prevention than cure: optimal patient preparation for renal replacement therapy.Huang, X., Carrero, JJ.[2018]

Citations

'Reality and desire' in the care of advanced chronic kidney disease. [2020]
Implementation of a cooperative program for peritoneal dialysis. [2019]
Better prevention than cure: optimal patient preparation for renal replacement therapy. [2018]
Quality Improvement Initiative to Increase Modality Education in a Nephrology Clinic During the COVID-19 Pandemic. [2023]
Efficacy of a disease management program focused on acquisition of self-management skills in pre-dialysis patients with diabetic nephropathy: 24 months follow-up. [2022]
Telemedicine to Promote Patient Safety: Use of Phone-Based Interactive Voice-Response System to Reduce Adverse Safety Events in Pre-dialysis CKD. [2022]
Implementation of a renal pharmacist consultant service - Information sharing in paper versus digital form. [2021]
CKD as an underrecognized threat to patient safety. [2023]
Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study. [2019]
Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy. [2022]
Renal replacement therapy in adult and pediatric intensive care : Recommendations by an expert panel from the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) French Group for Pediatric Intensive Care Emergencies (GFRUP) the French Dialysis Society (SFD). [2023]
Acute Renal Replacement Therapy in Intensive Care Units versus Outside Intensive Care Units: Are They Different? [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security